2025 Publication Archive
Health Technology Assessment with Dynamic Prevalence of Disease Over Time
Padula WV, Pontinha VM
Available at SSRN: https://ssrn.com/abstract=5258987 or http://dx.doi.org/10.2139/ssrn.5258987
Multidisciplinary teams in clinical lipidology and cardiometabolic care: A National Lipid Association Expert Clinical Review.
Cheeley MK, Kirkpatrick CF, Brown EE, Dixon DL, Gunter H, Osborn DS, Wilkinson MJ.
J Clin Lipidol. 2025 May 29:S1933-2874(25)00283-1. doi: 10.1016/j.jacl.2025.05.002.
Impact of pharmacist-physician collaborative care on diabetes quality measure achievement in primary care.
Wagner TD*, Dixon DL, Musselman KT, Shin Y, Dozmorov MG, Musselman KT, Buffington TM, Hyder H, Kirschner B, Jones RM, Salgado TM.
J Manag Care Spec Pharm. 2025;31(6):565-577
Tolerance for chemotherapy-induced peripheral neuropathy among women with metastatic breast cancer: A discrete-choice experiment.
Radwan RM*, Schuster A, Hertz DL, Lustberg MB, Vachhani H, Zacholski EH, Sheppard VB, Bridges JFP, Salgado TM.
Breast Cancer Res Treat. 2025;212(1):149-159. doi: 10.1007/s10549-025-07715-5
Factors influencing the decision to discontinue treatment due to chemotherapy-induced peripheral neuropathy among patients with metastatic breast cancer: a best-worst scaling
Rotana M Radwan, John F P Bridges, Daniel L Hertz, Maryam B Lustberg, Hetal Vachhani, Erin Hickey Zacholski, Vanessa B Sheppard, Teresa M Salgado
The case for value-based care in kidney transplantation: insights into geography, growth, and financial models.
Paulus AB, Kumar D, Pontinha VM.
Current Opinion in Organ Transplantation 30(2):p 87-95, April 2025. | DOI: 10.1097/MOT.0000000000001204
Investigating the Time-Varying Nature of Medication Adherence Predictors: An Experimental Approach Using Andersen's Behavioral Model of Health Services Use.
Pontinha VM, Patterson JA, Dixon DL, Carroll NV, Mays D, Farris KB, Holdford DA
Pharmacy (Basel). 2025 Apr 9;13(2):53. doi: 10.3390/pharmacy13020053.
Prescribing Patterns of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients With Type 2 Diabetes at Cardiology, Endocrinology, and Primary Care Visits
Dixon DL, Salgado TM, Robinson A, Carbone S, Wagner TD, Hyder H, Kirschner B, Musselman KT, Buffington TM, Sabo RT.
Mayo Clin Proc. 2025 Apr;100(4):647-656. doi: 10.1016/j.mayocp.2024.08.026.
Impact of Glucagon-like Peptide-1 Receptor Agonists on Metabolic Health in Liver Transplant Recipients.
Yakubu I*, Spengler J, Taylor P, LaPorte M, Brown A, Sterling S, Agegnehu B, Iaria A, Marks R, Sprague T, Pontinha VM, Patel V, Patidar KR, Siddiqui MS.
Transplantation. 2025 Mar 25. doi: 10.1097/TP.0000000000005361
Characterizing pharmacy deserts and designing a model to minimize inequities in pharmacy distribution in Virginia.
Boyle J, Wittenauer R, Ramella S, Juran C, Bucheit JD, Sisson EM, Kelly Goode JV, Gatewood SS, Salgado TM.
J Am Pharm Assoc (2003). 2025 Mar-Apr;65(2):102334. doi: 10.1016/j.japh.2025.102334.
Modeling Incremental Benefit of Medication Reconciliation on ICU Outcomes
Harris HA, Chan DM, Ellwein Fix L, Chouinard M, Salgado TM, Kang L, Bearman G.
Jt Comm J Qual Patient Saf. 2025;S1553-7250(25)00055-8. doi: 10.1016/j.jcjq.2025.02.001